Clinical Trial Update: SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. [Phase 2]

View source ↗

Summary

Phase 2 SOLSTICE trial update sponsored by Vir Biotechnology, evaluating a combination therapy for chronic hepatitis D infection; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Snippet

Sponsor: Vir Biotechnology, Inc. | Conditions: Hepatitis D, Chronic | Phase 2 | Status: ACTIVE_NOT_RECRUITING